Long-Term Safety of Drug-Eluting and Bare-Metal Stents: Evidence From a Comprehensive Network Meta-Analysis.

  title={Long-Term Safety of Drug-Eluting and Bare-Metal Stents: Evidence From a Comprehensive Network Meta-Analysis.},
  author={Tullio Palmerini and Umberto de Benedetto and Giuseppe G. L. Biondi-Zoccai and Diego Della Riva and Letizia Bacchi-Reggiani and P. C. Smits and Georgios J. Vlachojannis and Lisette Okkels Jensen and Evald H\oj Christiansen and Kl{\'a}ra Berencsi and Marco Valgimigli and Carlotta Orlandi and Mario Petrou and Claudio Rapezzi and Gregg Whitney Stone},
  journal={Journal of the American College of Cardiology},
  volume={65 23},
BACKGROUND Previous meta-analyses have investigated the relative safety and efficacy profiles of different types of drug-eluting stents (DES) and bare-metal stents (BMS); however, most prior trials in these meta-analyses reported follow-up to only 1 year, and as such, the relative long-term safety and efficacy of these devices are unknown. Many recent studies have now reported extended follow-up data. OBJECTIVES This study sought to investigate the long-term safety and efficacy of durable… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 5 times over the past 90 days. VIEW TWEETS
79 Extracted Citations
42 Extracted References
Similar Papers

Citing Papers

Publications influenced by this paper.
Showing 1-10 of 79 extracted citations

Referenced Papers

Publications referenced by this paper.
Showing 1-10 of 42 references

Primary outcomes of the EVOLVE II Trial: a prospective randomized investigation of a novel bioabsorbable polymer-coated, everolimus-eluting coronary stent

  • DJ Kereiakes, IT Meredith, S Windecker
  • Presented at: American Heart Association…
  • 2014
Highly Influential
6 Excerpts

Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent: 3 year follow-up from the COMPARE II trial (abstr)

  • GJ Vlachojannis, PC Smits, SH Hofma
  • J Am Coll Cardiol
  • 2014

Improved Safety and Reduction in Stent Thrombosis after Everolimus-Eluting Stents versus Sirolimus-Eluting Stents in Patients with Coronary Artery Disease: SORT OUT IV 5-Year (abstr)

  • LO Jensen, P Thayssen, EH Christiansen
  • J Am Coll Cardiol
  • 2014
1 Excerpt

Similar Papers

Loading similar papers…